Eli Lilly and Company (NYSE: LLY) today announced updated results from the Phase 3 EMBER-3 study of Inluriyo (imlunestrant), an oral estrogen receptor antagonist, in patients with estrogen receptor ...
Abstract: Genetic programming (GP) and fuzzy logic are used to automatically segment mammography images. GP allows the evolution of optimized segmentation models, guided by a fuzzy logic-based fitness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback